Form 8-K · Current report
Merck & Co. 8-K, filed Oct 13, 2026
- Filed
- CIK
- 0000310158
- Accession no.
- 0000310158-26-000237
Summary
Merck & Co. announced that Paul J. Diaz, a managing partner at Cressey & Company, will join its board of directors effective Nov. 1, 2026, and will stand for election by shareholders in May 2027, bringing the board to 14 members. The board appointed Diaz to its Audit Committee and Research Committee, and chairman and CEO Rob Davis said Diaz brings extensive healthcare leadership and business expertise.
Key points
- Diaz's appointment takes effect Nov. 1, 2026, and he will stand for shareholder election in May 2027.
- Diaz will serve on both the Audit Committee and the Research Committee.
- Diaz previously served as president and CEO of Myriad Genetics and, before that, of Kindred Healthcare.
- Diaz is a managing partner at Cressey & Company and serves on the boards of Centene Corporation, Johns Hopkins Medicine and the Georgetown University Law Center Board of Visitors.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
From the filing
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the “Company”) on October 13, 2026, attached as Exhibit 99.1, announcing the election of Paul J. Diaz to the Company’s Board of Directors (the “Board”), effective November 1, 2026. The Board appointed Mr. Diaz as a member of both the Audit Committee and the Research Committee of the Board. For his service on the Board, Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.